Crescendo Biologics’ CEO, Peter Pack to present and participate in panel at Biotech and Money 2017

Crescendo Biologics’ CEO, Peter Pack to present and participate in panel at Biotech and Money 2017

view PDF

Crescendo Biologics partners with software-provider, Genedata, on next-generation immuno-oncology and ADC programs

Crescendo Biologics partners with software-provider, Genedata, on next-generation immuno-oncology and ADC programs.

view PDF

Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m

Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m
view PDF

Crescendo strengthens IP portfolio with U.S. patent

Crescendo strengthens IP portfolio with U.S. patent to transgenic mouse platform for generating Humabody® therapeutics.
view PDF

Key Oncology Data on Humabody™ Drug Conjugates

Key Oncology Data on Humabody™ Drug Conjugates.
view PDF

Crescendo Appoints New Chairman

Crescendo Appoints New Chairman
view PDF